ENTO
Entero Therapeutics
ENTO
ENTO
9 hedge funds and large institutions have $47.6K invested in Entero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$6.31K |
| 2 |
Jane Street
New York
|
+$5.09K |
| 3 |
Renaissance Technologies
New York
|
+$5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.97K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$15K |
| 2 |
HF
HRT Financial
New York
|
-$13K |
| 3 |
JC
JB Capital
Wethersfield,
Connecticut
|
-$4.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $14.6K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $8.22K | -$15K | -12,474 | -65% |
|
|
TSS
3
Two Sigma Securities
New York
| $6.31K | +$6.31K | +5,259 | New |
|
|
4
Jane Street
New York
| $5.09K | +$5.09K | +4,243 | New |
|
|
5
Renaissance Technologies
New York
| $5K | +$5K | +4,167 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $4.97K | +$4.97K | +4,138 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2.03K | -$2 | -2 | -0.1% |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $1.32K | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| $17 | +$1 | +1 | +8% |
|
|
HF
10
HRT Financial
New York
| – | -$13K | -9,534 | Closed |
|
|
JC
11
JB Capital
Wethersfield,
Connecticut
| – | -$4.8K | -3,333 | Closed |
|